News Articles
Back to list

NTEC Announces Venture Alliance Partner Program Featuring Ten Key VC Firms from Around the U.S. Including Texas-Based Sevin Rosen and Santé Ventures

07/26/2010

FRISCO, TX (VentureWire) -- The North Texas Enterprise Center (NTEC), a nonprofit organization dedicated to assisting MedTech and CleanTech start-up companies, has announced the formation of their Venture Alliance Partner Program (VAP).  The VAP Program was created to enhance start-up company deal visibility for local and out of state venture capital funds, facilitate deal syndication among participating partners and to provide increased emerging company access to institutional investors. 

“We recognized the intersection of need and opportunity and decided to provide a solution in the form of our VAP Program,” said Larry Calton, Executive Director at NTEC.  The VAP Program is targeting venture capital firms, most of which are out of state, that commit to spending from two days a month to two days per quarter maintaining “office hours” at the NTEC facility in Frisco.  NTEC will help identify and screen companies and coordinate meetings with the investors during their office hours at the facility.”

“For startup firms it is often difficult to get access to capital. This program should make the process much more efficient and serve both, the start-up community and the venture capital community,” said Dr. Hubert Zajicek, Senior Director at NTEC. 

NTEC has also partnered with Southern Methodist University (SMU) to utilize business students to assist with due diligence and market research on companies applying for VAP consideration.  Dallas-based Sevin Rosen Funds (SRF) was the first venture fund to join the VAP Program, according to Jon Bayless, SRF General Partner.

 

SMU Logo“SMU has long been committed to venture capital as a core component of a healthy entrepreneurial environment, and partnering with NTEC on the Venture Alliance fits perfectly with our goal of being a top educational resource for future generations of private equity executives and venture capitalists,” said John F. Terry, adjunct professor for the Caruth Institute for Entrepreneurship at the Cox School of Business at SMU and founding board member of the SMU MBA Venture Fund.

 

“The VAP Program launched by NTEC should be a valuable resource to entrepreneurs starting businesses in North Texas.  We are pleased to partner with NTEC in this effort, and anticipate that the VAP Program will help identify capable local entrepreneurs and assist them in attracting venture capital from us and others,” explained Bayless.

 

“The NTEC Venture Alliance Partner program is a great deal flow resource for Chrysalis Ventures as we continue to actively invest from our $175 million fund which closed in 2008,” said Alan Ying of Louisville, KY-based Chrysalis.  “The focus on the medical technology sector as it relates to healthcare technology services is a great fit for our investment thesis of investing in businesses that offer productivity-enhancing solutions to make the delivery of healthcare more efficient.”

 

Below are the venture capital firms that make up the NTEC VAP:

ARBORETUM PARTNERS

LogoArboretum Ventures is an early-stage venture capital firm specializing in the healthcare sector. It invests throughout the United States, but with a special interest in the Midwest. More than simply a financial resource, Arboretum Ventures is a collaborative, value-added investor actively engaging its companies in strategy, operations, recruiting, fundraising and exit planning.  Arboretum Ventures aims to transform young companies into mature and thriving businesses that improve patient outcomes and lower the cost of care, thereby generating superior returns for the entrepreneurs and its investors. Founded in 2002 and headquartered in Ann Arbor, Michigan, Arboretum currently manages approximately $97 million in capital. Market Place Building / 30 Detroit Street, Suite 301 / Ann Arbor, MI 48104 / 734.998.3688.  www.arboretumvc.com.

  

BALLAST POINT VENTURES

LogoBallast Point Ventures is a venture capital firm providing expansion capital to rapidly growing private companies located primarily in the Southeast and Texas. Ballast Point Ventures partners with talented and driven management teams to achieve profitable long-term growth. It understands the importance of making the right decisions for the long run, and it provides its entrepreneur partners with extensive experience, critical resources, valuable introductions and helpful insights as they strive to build industry-leading companies. 880 Carillon Parkway / St. Petersburg, FL 33716 / 727.567.1500.  www.ballastpointventures.com.

 

CHRYSALIS VENTURES

LogoFounded in 1993, Chrysalis Ventures manages one of Mid-America’s largest funds for early-stage and growth investments with approximately $400 million under management. Focused on partnering with entrepreneurs to build enduring businesses in industries undergoing significant transformation, Chrysalis has invested in over 65 companies primarily in the healthcare and technology sectors. With headquarters in Louisville, KY, Chrysalis has an office in Houston and has invested in companies in Dallas, Austin and Houston, including its recent successful exit of MedServe, a Houston-based provider of medical waste management services to hospitals and clinics which was acquired by and became a wholly-owned subsidiary of Stericycle, Inc.  (NASDAQ:SRCL) in December 2009. 101 South Fifth Street, Suite 1650 / Louisville, KY 40202 / 502.583.7644.  www.chrysalisventures.com.

   

HERON CAPITAL     

Heron Capital is a venture capital fund dedicated to investing in mid and growth stage companies focused on the life sciences, including therapeutic medical devices, diagnostics and healthcare services. The firm is advised by a world-renowned network of scientists and physicians, as well as entrepreneurs and leaders of national and multinational corporations. The mission of the Fund is to identify and invest in companies with great commercial potential, strong intellectual property and the highest quality management.  One Indiana Square / 211 North Pennsylvania Street, Suite 2250 / Indianapolis, IN 46204 / 317.686.1950.  www.heroncap.com.

 

H.I.G. BIOVENTURES

HIG_BioVentures_RGB_logo

H.I.G. BioVentures invests in companies developing innovative products for significant unmet medical needs in therapeutics, medical device technology, specialty pharmaceuticals and diagnostics. A natural extension of the broader H.I.G. Capital platform, H.I.G. BioVentures invests across a broad range of stages and leverages its team of seasoned senior investment professionals who have over 75 combined years of experience in life sciences investing, operations, business development, sales and marketing, research management, financ, and technology development. Our ability to leverage the broader H.I.G. infrastructure and resources provides significant value to our portfolio companies and partners. H.I.G. BioVentures is the life sciences venture capital affiliate of H.I.G. Capital, a leading global private investment firm with over $7.5 billion of capital under management and U.S. offices in Atlanta, Boston, Miami, New York and San Francisco.  3050 Peachtree Road NW, Suite 360 / Atlanta, GA 30305 / 404.504.9333.   www.higbio.com.

  

NORO-MOSELY PARTNERS     

LogoSince 1983, Noro-Moseley Partners has been a leading Southeast venture capital firm bringing energy, connections and domain expertise to the strongest entrepreneurs in the region. Over the past 25 years, NMP has become an important part of the Southeast’s community of entrepreneurs and innovators. While focused on generating significant returns for investors, NMP works hard to be the entrepreneur’s partner of choice in the Southeast.  NMP has invested in more than 160 promising start-ups and early-growth-stage companies in the technology, healthcare and business services industries. The firm has worked with a wide range of entrepreneurs and has assembled an investment team with the right mix of skills to assist entrepreneurs in growing their companies.  9 North Parkway Square / Northside Parkway NW /. Atlanta, Georgia 30327-3054 / 404.233.1966.   www.noromoseley.com.

 

PROLOG VENTURES

LogoProlog Ventures a venture capital firm specializing in life sciences. Since its launch in 2001, it has supported more than 25 young companies. It invests in traditional healthcare opportunities as well as emerging areas — such as nutrition, wellness, and green technology — in which it has built one of the largest portfolios in the country.  7701 Forsyth Blvd., Suite 1095 / St. Louis, MO 63105 / 314.743.2400.  www.prologventures.com.

 

 

RIVER CITIES CAPITAL FUNDS

Logo

Founded in 1994, River Cities Capital Funds is one of the most active and experienced venture funds investing in the Midwest and Southeastern United States. The firm is currently investing out of Fund IV closed in March 2008 at $120 million.  River Cities Capital Funds has $390 million under management and over 75 investments over fourteen years, and the firm has established itself as a preferred partner among the regional entrepreneurial and broader venture capital communities. River Cities seeks to invest in high growth information technology and healthcare companies that have a material customer base and are nearing profitability.   221 East Fourth Street, Suite 2400 / Cincinnati, OH 45202-4151 \ 513.621.9700.  www.rccf.com.

 

SANTÉ VENTURES

Santé Ventures invests in early-stage life science and healthcare companies. Experience has taught it that new ventures are challenging and risky endeavors, and that the best people can often make the crucial difference between success and failure. With that in mind, Santé Ventures focuses on developing lasting, well-aligned partnerships with exceptional entrepreneurs and executives to build valuable companies.  In addition to capital, Santé Ventures provides deep healthcare domain expertise and an extensive network of industry contacts and resources. Frost Bank Tower / 401 Congress Avenue, Suite 2950 / Austin, Texas 78701 / 512.721.1200.  www.santeventures.com.

 

SEVIN ROSEN FUNDS

 

Sevin Rosen Funds PictureSevin Rosen Funds is a top-tier venture capital firm with a record of funding successful companies since 1981. The Sevin Rosen partnership has consistently made early-stage investments in pioneering technologies and companies with the potential to create new markets. The partners’ broad range of venture and operating experiences in successful technology companies translates into a sustained commitment and contribution to the development of the ventures funded. The firm has Texas offices in Dallas and Austin.  Two Galleria Tower / 13445 Noel Road, Suite 1670 / Dallas Texas 75240-5003 / 972.702.1100.  www.srfunds.com.

 

About NTEC

The North Texas Enterprise Center (NTEC) is a not-for-profit organization based in Frisco, Texas, that operates as a business accelerator – providing a broad spectrum of services and support to MedTech and CleanTech start-up companies.  NTEC, which was founded in 2002, has grown to become one of the largest technology start-up accelerators in the South Central U.S.  NTEC’s core mission is assisting entrepreneurs with the challenging task of starting and expanding a new, technology-based business venture.  The target result of that mission is local and regional economic development, new job creation and industry diversification.  For more information, please visit www.ntec-inc.org.